Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 23641693)

Published in Bioanalysis on May 01, 2013

Authors

Montserrat Carrasco-Triguero1, Joo-Hee Yi, Randall Dere, Zhihua Julia Qiu, Corinna Lei, Yanhong Li, Connie Mahood, Bei Wang, Douglas Leipold, Kirsten Achilles Poon, Surinder Kaur

Author Affiliations

1: Department of Bioanalytical Sciences, Genentech, South San Francisco, CA 94080, USA.

Articles by these authors

Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem (2005) 6.05

Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet (2009) 3.90

Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med (2009) 3.13

Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer. J Clin Oncol (2010) 3.06

Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol (2009) 2.58

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat Biotechnol (2012) 2.43

Effectiveness of PhysioDirect telephone assessment and advice services for patients with musculoskeletal problems: pragmatic randomised controlled trial. BMJ (2013) 2.14

Effects of nitrogen sources on cell growth and lipid accumulation of green alga Neochloris oleoabundans. Appl Microbiol Biotechnol (2008) 2.07

Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells. Proc Natl Acad Sci U S A (2010) 1.75

Extraordinary room-temperature photoluminescence in triangular WS2 monolayers. Nano Lett (2012) 1.74

Drosophila glypicans control the cell-to-cell movement of Hedgehog by a dynamin-independent process. Development (2004) 1.73

A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther (2002) 1.63

Whole-genome sequencing reveals untapped genetic potential in Africa's indigenous cereal crop sorghum. Nat Commun (2013) 1.60

First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis (2004) 1.60

Enhancement of lipid production using biochemical, genetic and transcription factor engineering approaches. J Biotechnol (2009) 1.59

Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation (2014) 1.57

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer. Cancer Chemother Pharmacol (2012) 1.57

Tlx controls proliferation and patterning of lateral telencephalic progenitor domains. J Neurosci (2003) 1.56

Henoch-Schönlein purpura with hypocomplementemia. Pediatr Nephrol (2012) 1.54

DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury. Proc Natl Acad Sci U S A (2013) 1.53

DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity. J Cell Biol (2011) 1.45

A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation. Liver Int (2011) 1.43

Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats. Bioconjug Chem (2011) 1.40

The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein. Chemistry (2004) 1.35

Primary-care patients' expectations and experiences of online cognitive behavioural therapy for depression: a qualitative study. Health Expect (2009) 1.33

Nitrogen-doped graphene: beyond single substitution and enhanced molecular sensing. Sci Rep (2012) 1.31

Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors. Clin Cancer Res (2011) 1.29

Dialkylphosphates (DAPs) in fruits and vegetables may confound biomonitoring in organophosphorus insecticide exposure and risk assessment. J Agric Food Chem (2008) 1.29

Distinct temporal requirements for the homeobox gene Gsx2 in specifying striatal and olfactory bulb neuronal fates. Neuron (2009) 1.28

Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. J Infect Dis (2013) 1.28

AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. Blood (2013) 1.26

An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem (2011) 1.25

JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis. J Cell Biol (2013) 1.22

Taking ecological function seriously: soil microbial communities can obviate allelopathic effects of released metabolites. PLoS One (2009) 1.22

Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis (2005) 1.22

Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals. Mol Cell Biol (2009) 1.21

Remodeling bacterial polysaccharides by metabolic pathway engineering. Proc Natl Acad Sci U S A (2009) 1.17

Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proc Natl Acad Sci U S A (2009) 1.17

Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J Pharm Sci (2006) 1.15

Improved cycling time-trial performance after ingestion of a caffeine energy drink. Int J Sport Nutr Exerc Metab (2009) 1.15

Quantitative in situ assay of salicylic acid in tobacco leaves using a genetically modified biosensor strain of Acinetobacter sp. ADP1. Plant J (2006) 1.12

Catabolic fate and pharmacokinetic characterization of trastuzumab emtansine (T-DM1): an emphasis on preclinical and clinical catabolism. Curr Drug Metab (2012) 1.12

2012 white paper on recent issues in bioanalysis and alignment of multiple guidelines. Bioanalysis (2012) 1.09

Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res (2011) 1.08

Clinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer. J Clin Pharmacol (2011) 1.08

1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity. J Med Chem (2009) 1.08

Comparative genomics of parasitic silkworm microsporidia reveal an association between genome expansion and host adaptation. BMC Genomics (2013) 1.07

Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens (2009) 1.07

Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein. J Immunol (2011) 1.07

Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg (2007) 1.06

A sialyltransferase mutant with decreased donor hydrolysis and reduced sialidase activities for directly sialylating LewisX. ACS Chem Biol (2012) 1.06

Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry. Anal Biochem (2011) 1.06

Toward the synthesis of artificial proteins: the discovery of an amphiphilic helical peptoid assembly. Chem Biol (2002) 1.05

The homeobox gene Gsh2 is required for retinoid production in the embryonic mouse telencephalon. Development (2004) 1.05

N-Terminal 112 amino acid residues are not required for the sialyltransferase activity of Photobacterium damsela alpha2,6-sialyltransferase. Biotechnol Lett (2007) 1.04

'PhysioDirect' telephone assessment and advice services for physiotherapy: protocol for a pragmatic randomised controlled trial. BMC Health Serv Res (2009) 1.04

Homeobox genes Gsx1 and Gsx2 differentially regulate telencephalic progenitor maturation. Proc Natl Acad Sci U S A (2011) 1.03

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol (2007) 1.02

Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial. Br J Psychiatry (2010) 1.00

Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J Pharm Sci (2005) 1.00

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF. Circ Heart Fail (2013) 1.00

Sialidase substrate specificity studies using chemoenzymatically synthesized sialosides containing C5-modified sialic acids. Org Biomol Chem (2009) 0.99

Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis. J Biol Chem (2010) 0.99

The mouse and ferret models for studying the novel avian-origin human influenza A (H7N9) virus. Virol J (2013) 0.99

Proteomic analysis of spore wall proteins and identification of two spore wall proteins from Nosema bombycis (Microsporidia). Proteomics (2008) 0.98

Efficient one-pot multienzyme synthesis of UDP-sugars using a promiscuous UDP-sugar pyrophosphorylase from Bifidobacterium longum (BLUSP). Chem Commun (Camb) (2012) 0.98

Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. J Pharm Sci (2006) 0.98

One-pot three-enzyme synthesis of UDP-GlcNAc derivatives. Chem Commun (Camb) (2011) 0.97

Suppression of keratinocyte stratification by a dominant negative JunB mutant without blocking cell proliferation. Genes Cells (2007) 0.97

Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities. Glycobiology (2008) 0.97

Mechanisms of mRNA translation of interferon stimulated genes. Cytokine (2010) 0.97

Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China. Vaccine (2011) 0.96

Probe sialidase substrate specificity using chemoenzymatically synthesized sialosides containing C9-modified sialic acid. Chem Commun (Camb) (2012) 0.96

Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper. Bioanalysis (2013) 0.96

α6β4 integrin, a master regulator of expression of integrins in human keratinocytes. J Biol Chem (2012) 0.95

Impaired spatial learning and memory after sevoflurane-nitrous oxide anesthesia in aged rats is associated with down-regulated cAMP/CREB signaling. PLoS One (2013) 0.95

Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure. Circ Cardiovasc Qual Outcomes (2010) 0.95

Highly efficient chemoenzymatic synthesis of β1-3-linked galactosides. Chem Commun (Camb) (2010) 0.95

Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae. Antimicrob Agents Chemother (2013) 0.94

Clinicopathological study of hysterectomies. J Indian Med Assoc (2002) 0.94

DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma. Mol Cancer Ther (2013) 0.94

Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin Res Cardiol (2011) 0.94

Preclinical safety profile of trastuzumab emtansine (T-DM1): mechanism of action of its cytotoxic component retained with improved tolerability. Toxicol Appl Pharmacol (2013) 0.94

An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer. Clin Pharmacokinet (2013) 0.93

Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK? Bioorg Med Chem Lett (2008) 0.93

Fluorescent labeling agents change binding profiles of glycan-binding proteins. Mol Biosyst (2011) 0.93

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics. Mol Neurodegener (2014) 0.93

The prevalence of subjective symptoms after exposure to arsenic in drinking water in Inner Mongolia, China. J Epidemiol (2003) 0.92

Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles. Nanomedicine (2012) 0.92

Postexercise carbohydrate-protein supplementation improves subsequent exercise performance and intracellular signaling for protein synthesis. J Strength Cond Res (2011) 0.92

The interplays between autophagy and apoptosis induced by enterovirus 71. PLoS One (2013) 0.92

Trans-sialidase activity of Photobacterium damsela alpha2,6-sialyltransferase and its application in the synthesis of sialosides. Glycobiology (2009) 0.91

Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro. Drug Metab Dispos (2008) 0.91